Page last updated: 2024-08-16

temozolomide and cyclin d1

temozolomide has been researched along with cyclin d1 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Agnihotri, S; Aldape, K; Clarke, ID; Dirks, PB; Fuller, GN; Gajadhar, A; Guha, A; Hawkins, C; Kesari, S; McGlade, CJ; Mischel, PS; Munoz, DM; Restrepo, A; Smith, CJ; Stanford, WL; Wolf, A1
Chen, J; Hu, G; Lu, Y; Luo, C; Qian, J; Wang, J; Wang, Q1
Belmonte, G; Miracco, C; Pirtoli, L; Tini, P; Toscano, M1
Dai, D; Li, Y; Li, Z; Lu, Y; Wang, C; Wang, J; Zhang, D; Zhou, M1
Chen, Y; Jiang, W; Kuang, W; Liu, Z; Tian, Y1
Alaniz, L; Berner, S; Bonadeo, N; Cervio, A; Chimento, A; Cristina, C; Demarchi, G; Perrone, S; Sevlever, G; Spinelli, FM; Valla, S; Vitale, DL1

Other Studies

6 other study(ies) available for temozolomide and cyclin d1

ArticleYear
A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas.
    The Journal of experimental medicine, 2011, Apr-11, Volume: 208, Issue:4

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; GATA4 Transcription Factor; Glioblastoma; Humans; Mice; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins

2011
Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
    Journal of neuro-oncology, 2013, Volume: 112, Issue:1

    Topics: Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin D1; Dacarbazine; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioma; Green Fluorescent Proteins; GTPase-Activating Proteins; Humans; Multidrug Resistance-Associated Proteins; Neoplasm Invasiveness; RNA Interference; RNA, Messenger; RNA, Small Interfering; Temozolomide; Time Factors; Transfection

2013
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism?
    Anticancer research, 2016, Volume: 36, Issue:8

    Topics: Adult; Apoptosis; Autophagy; Beclin-1; Cell Line, Tumor; Cyclin D1; Dacarbazine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Temozolomide

2016
Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 51, Issue:6

    Topics: Adult; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Middle Aged; Temozolomide

2018
The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ).
    Cancer biology & therapy, 2021, 06-03, Volume: 22, Issue:5-6

    Topics: Brain Neoplasms; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Glioma; Humans; MicroRNAs; Polycomb Repressive Complex 2; Temozolomide

2021
β-Catenin is reduced in membranes of human prolactinoma cells and it is inhibited by temozolomide in prolactin secreting tumor models.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2022, Volume: 44, Issue:1

    Topics: Animals; beta Catenin; Cyclin D1; Humans; Mice; Models, Theoretical; Pituitary Neoplasms; Prolactin; Prolactinoma; Temozolomide

2022